Creative Planning’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Creative Planning’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-20	Closed	-$1K	–	4253
2017 Q2	$1K	Hold	20	–	–	﹤0.01%	4552
2017 Q1	$1K	Hold	20	–	–	﹤0.01%	4556
2016 Q4	$1K	Sell	20 -10,480	-100%	-$561K	﹤0.01%	4544
2016 Q3	$631K	Hold	10,500	–	–	﹤0.01%	777
2016 Q2	$537K	Sell	10,500 -25	-0.2%	-$1.07K	﹤0.01%	741
2016 Q1	$311K	Hold	10,525	–	–	﹤0.01%	980
2015 Q4	$477K	Buy	+10,525	New	+$552K	﹤0.01%	785
2015 Q2	–	Sell	-7,051	Closed	-$546K	–	3501
2015 Q1	$546K	Buy	+7,051	New	+$406K	0.01%	699

Other funds holding ONCE

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Creative Planning's ONCE Position: Q3 2017 in Review

Creative Planning sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q3 2017, closing a stake of 20 shares — an estimated $1K sold.

Creative Planning first reported a position in ONCE in Q1 2015 and held it in 8 quarters. The position peaked at $631K in Q3 2016. 163 funds tracked by Wall St. Rank hold ONCE as of Q3 2017.

Creative Planning reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q3 2017 after selling out during the quarter.
Creative Planning sold 20 Spark Therapeutics, Inc. Common Stock shares in Q3 2017, an estimated $1K.
Creative Planning first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2015 and held it in 8 quarters.
Creative Planning's Spark Therapeutics, Inc. Common Stock position peaked at $631K in Q3 2016.
163 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q3 2017.

Based on Creative Planning's 13F filing for Q3 2017, filed 17 Oct 2017.